Kim (2019)
134
|
Age, (gender), BMI, SBP, HR, HT, CHD, Hb, Na, Cre, NT‐proBNP, LVEF, medications |
Chen (2018)
101
|
None |
Cooper (2018)
102
|
Age, gender, race, BMI, SBP, HrR, NYHA, CHD, AF, PVD, COPD, CKD, ACE‐I, ARB, diuretics |
Iorio (2018)
137
|
Age, gender |
Kristensen (2018)
103
|
None |
Retwinski (2018)
136
|
None |
Rorth (2018)
104
|
Age, gender, education, IHD, AF, CKD, COPD, HT, stroke, cancer, medications |
Sandesara (2018)
105
|
None |
Takimura (2018)
135
|
Age, duration after previous HF, Hb, UA, LVEF, LAVI |
Dauriz (2017)
106
|
Age, gender, smoking, BMI, SBP, eGFR, LVEF, IHD, HT, statin, stroke, COPD, Hb |
Farre (2017)
107
|
Age, gender, recent HF, anaemia, valvular disease, IHD, CKD, dialysis, AF, cardiac conduction disorders, cancer, stroke, dementia, cirrhosis number of hospitalization, visits to emergency department |
Kristensen (2017)
108
|
Age, gender, recent HF, LVEF, HrR, eGFR, NT‐proBNP, neutrophils, COPD, MI, ischaemic origin |
Mohamedali (2017)
109
|
None |
Echouffo‐Tcheugui (2016)
110
|
Age, gender, race, LVEF, NYHA, AF, ischaemic cardiomyopathy, ECG (LBBB, wide QRS), cardiac conduction disorders, HF duration, Cre, history of syncope, FH of sudden death, CHD, ventricular tachycardia medications |
Kristensen (2016)
111
|
None |
Ruigomez (2016)
112
|
Age, gender, smoking, alcohol, BMI, residence, IHD, stroke, HT, AF, hyperlipidaemia, COPD, asthma, RD, visiting hospital in the previous year |
Kaneko (2015)
113
|
Age, IHD, DBP, HrR, diuretics |
Takeda (2015)
114
|
None |
Carrasco‐Sanchez (2014)
115
|
Age, NYHA, GFR, Na, BMI, anaemia, PVD, beta‐blocker, ACE‐Is, ARBs |
Cubbon (2014)
116
|
Pulmonary congestion, previous HF, diuretics |
Paoletti (2014)
117
|
None |
Sakata (2014)
118
|
Age, gender, smoking, BMI, SBP, HT, dyslipidaemia, LVEF, HrR, Hb, Cre, BNP, medications |
Larina (2013)
119
|
None |
Sarma (2013)
120
|
Age, gender, smoking, BMI, SBP, EF, Na, BUN, QRS duration, BNP/NT‐proBNP, AF, HT, CKD, stroke, medications |
Verbrugge (2012)
121
|
Obesity, HT, COPD, CKD, NYHA, right ventricular function, ischaemic aetiology of HF |
Deedwania (2011)
122
|
Propensity‐matched for age, gender, smoking, BMI, SBP, DBP, HrR, others (multiple) (previous diseases, laboratory data, medications) |
Martin (2011)
123
|
None |
Aguilar (2010)
124
|
Age, gender, obesity, ischaemic origin, NYHA |
Sze (2010)
125
|
Gender, NYHA, AF, wide QRS, HrR, one of renal function indicators, beta‐blocker, diuretics |
MacDonald (2008)
126
|
32 covariates (including age, gender, smoking, SBP, DBP, NYHA, LVEF, HrR, IHD, stroke, AT, pacemaker, various medications) |
Macdonald (2008)
127
|
Age, (gender), co‐morbidities (including CHD) |
Ghali (2007)
128
|
None |
Ruiz‐Ruiz (2007)
129
|
None |
Formiga (2006)
130
|
Age, gender, SBP, PIP |
Garcia (2005)
131
|
None |
Domanski (2003)
132
|
Age, gender, BMI, race, Cre, SBP, aetiology of HF, cholesterol, diuretics, vasodilators |
Shindler (1996)
133
|
Age, gender, race, EF, aetiology of left ventricular dysfunction, NYHA |
Harnett (1995)
85
|
Age, IHD, EF, Hb, albumin, DBP, LV mass |